The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Independent Grants for Learning & Change (IGLC) Track 2 - Call for Grant Applications (CGA): Vaccine Preventable Diseases in the IBD Patient
The mission of Pfizer Independent Grants for Learning & Change (IGL&C) is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. “Independent” means that the projects funded by Pfizer are the full responsibility of the recipient organization. Pfizer has no influence over any aspect of the projects and only asks for reports about the results and the impact of the projects in order to share them publicly.
Through this CGA we encourage organizations to submit grant requests that, if funded, will support education in a specific disease state, therapeutic area, or broader area of educational need.
The intent of this CGA is to encourage organizations to design educational programs to reach gastroenterologists and gastroenterology fellows, nurse practitioners, physician assistants, and all other healthcare professionals involved in the care and treatment of adult patients with inflammatory bowel disease (IBD).
Research has demonstrated that IBD patients do not always receive the preventive services they need. 1 This is particularly important for patients requiring long-term immune-suppressive therapy who are at increased risk of infections. 2 Adherence to appropriate vaccination guidelines can help mitigate this risk, yet a number of studies have demonstrated poor compliance with vaccination guidelines.
Programs with the highest likelihood of improving clinical gastroenterologists’ and gastroenterology fellows’, nurse practitioners’, physician assistants’, and all other healthcare professionals’ understanding of the current vaccination guidelines and the importance of vaccination in the care of IBD patients will be given the highest priority.
Deadline: July 28, 2017
The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
Individual projects requesting up to $250,000 will be considered. The grant amount Pfizer will be prepared to fund will depend upon the evaluation of the proposal and costs involved and will be stated clearly in the approval notification.